Article
Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients.
BMC neurology - 26 Mar 2008
Tronvik Erling, Stovner Lars J, Bovim Gunnar, White Linda R, Gladwin Amanda J, Owen Kathryn, Schrader Harald
Abstract excerpt
BACKGROUND: The main objective of this study was to investigate the angiotensin converting enzyme (ACE) genotype as a possible risk factor for migraine (both with and without aura) compared to controls. We also wanted to examine whether a clinical response to an ACE inhibitor, lisinopril, or an angiotensin II receptor blocker, candesartan, in migraine prophylaxis was related to ACE genotype. METHODS: 347 migraine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
